
|Videos|January 28, 2014
How Will Payers Manage Biosimilars?
Payers will encourage the use of biosimilars where appropriate through the use of step edits, lower tiers, and novel strategies, said Steven Lucio, Senior Director, Clinical Solutions and Pharmacy Program Development at Novation.
Advertisement
Payers will encourage the use of biosimilars where appropriate through the use of step edits, lower tiers, and novel strategies, said Steven Lucio, Senior Director, Clinical Solutions and Pharmacy Program Development at Novation.
This video was shot at the 2013 Academy of Managed Care Pharmacy in San Antonio, Texas.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists as the Glue in Cardio-Kidney-Metabolic Care
2
Extended-Interval Tarlatamab Dosing Offers Pharmacists More Flexible Administration Windows in SCLC
3
Pharmacists Weigh Health, Not Just Weight, in Obesity Care
4
Cancer Among 9/11 Survivors Is Accelerating 25 Years Later
5



































































































